These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies. Chun HG; Leyland-Jones B; Cheson BD J Clin Oncol; 1991 Jan; 9(1):175-88. PubMed ID: 1702143 [TBL] [Abstract][Full Text] [Related]
9. Phase I clinical trials with fludarabine phosphate. Von Hoff DD Semin Oncol; 1990 Oct; 17(5 Suppl 8):33-8. PubMed ID: 1699281 [TBL] [Abstract][Full Text] [Related]
10. [Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia]. Miyawaki S; Imamura M; Kobayashi S; Ohnishi K; Hodohara K; Mizoguchi H; Tomonaga M; Tango T; Ohno R Rinsho Ketsueki; 1999 Dec; 40(12):1236-44. PubMed ID: 10658476 [TBL] [Abstract][Full Text] [Related]
11. Clinical experience with fludarabine in hemato-oncology. Keating MJ; O'Brien S; McLaughlin P; Dimopoulos M; Gandhi V; Plunkett W; Lerner S; Kantarjian H; Estey E Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S83-91. PubMed ID: 9137961 [TBL] [Abstract][Full Text] [Related]
12. A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study. Elias L; Stock-Novack D; Head DR; Grever MR; Weick JK; Chapman RA; Godwin JE; Metz EN; Appelbaum FR Leukemia; 1993 Mar; 7(3):361-5. PubMed ID: 7680398 [TBL] [Abstract][Full Text] [Related]
13. Leukemia: A model for drug development. Keating MJ Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2598-604. PubMed ID: 9815664 [TBL] [Abstract][Full Text] [Related]
14. Use of fludarabine in the treatment of mantle cell lymphoma, Waldenström's macroglobulinemia and other uncommon B- and T-cell lymphoid malignancies. Johnson SA Hematol J; 2004; 5 Suppl 1():S50-61. PubMed ID: 15079153 [TBL] [Abstract][Full Text] [Related]
15. Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma. Hagenbeek A; Eghbali H; Monfardini S; Vitolo U; Hoskin PJ; de Wolf-Peeters C; MacLennan K; Staab-Renner E; Kalmus J; Schott A; Teodorovic I; Negrouk A; van Glabbeke M; Marcus R J Clin Oncol; 2006 Apr; 24(10):1590-6. PubMed ID: 16575010 [TBL] [Abstract][Full Text] [Related]
16. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia. Robak T; Lech-Maranda E; Robak P Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624 [TBL] [Abstract][Full Text] [Related]
18. Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma. Roberts JD; Smith MR; Feldman EJ; Cragg L; Millenson MM; Roboz GJ; Honeycutt C; Thune R; Padavic-Shaller K; Carter WH; Ramakrishnan V; Murgo AJ; Grant S Clin Cancer Res; 2006 Oct; 12(19):5809-16. PubMed ID: 17020988 [TBL] [Abstract][Full Text] [Related]
19. Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma. Tobinai K; Watanabe T; Ogura M; Morishima Y; Ogawa Y; Ishizawa K; Minami H; Utsunomiya A; Taniwaki M; Terauchi T; Nawano S; Matsusako M; Matsuno Y; Nakamura S; Mori S; Ohashi Y; Hayashi M; Seriu T; Hotta T J Clin Oncol; 2006 Jan; 24(1):174-80. PubMed ID: 16330664 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia. Foran JM; Oscier D; Orchard J; Johnson SA; Tighe M; Cullen MH; de Takats PG; Kraus C; Klein M; Lister TA J Clin Oncol; 1999 May; 17(5):1574-9. PubMed ID: 10334546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]